StockStory.org on MSN

ILMN Q1 deep dive: Clinical sequencing fuels growth as NovaSeq X demand surges

Genomics company Illumina (NASDAQ:ILMN) reported Q1 CY2026 results , with sales up 4.8% year on year to $1.09 billion. The ...
Morningstar

Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida

Increased adoption of clinical whole-genome sequencing is advancing diagnostics for rare diseases, which affect 15 million American children SAN DIEGO, Feb. 27, 2026 /PRNewswire/ -- Illumina, Inc.
San Diego Union-Tribune

Illumina partners with Nvidia on AI-powered genomic sequencing

San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy through a partnership with Nvidia. Nvidia — the Santa Clara tech company at ...
San Diego Union-Tribune

Scrappy San Diego startup goes toe-to-toe with gene-sequencing giant Illumina

Element Biosciences is going toe-to-toe with gene-sequencing giant Illumina, unveiling a device that can read DNA for half the price of the industry leader’s technology. On Thursday, Element ...
Hosted on MSN

Mastering whole genome sequencing coverage planning

Whole genome sequencing (WGS) delivers deep insights into genetics, but its reliability depends on aligning coverage depth and uniformity with the study’s goals. Current research and practical guides ...